Bck Partners, Inc. Eli Lilly & CO Transaction History

Bck Partners, Inc.

$193 Million
Q2 2024

A detailed history of Bck Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bck Partners, Inc. holds 284 shares of LLY stock, worth $256,369. This represents 0.13% of its overall portfolio holdings.

Number of Shares

284

Holding current value

$256,369

% of portfolio

0.13%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $205,863 - $258,167	284 New	284 $257,000
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $3.3 Million - $4.1 Million	14,059 New	14,059 $4.03 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

97.4M
Shares

$87.9 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$66.7 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$59.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$46.4 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$30.6 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bck Partners, Inc. with notifications on news.

Account